Edition:
India

Sun Pharmaceutical Industries Ltd (SUN.BO)

SUN.BO on Bombay Stock Exchange

464.70INR
18 May 2018
Change (% chg)

Rs-15.40 (-3.21%)
Prev Close
Rs480.10
Open
Rs489.70
Day's High
Rs489.70
Day's Low
Rs463.00
Volume
534,715
Avg. Vol
552,977
52-wk High
Rs656.75
52-wk Low
Rs433.15

Chart for

About

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New... (more)

Overall

Beta: 0.05
Market Cap(Mil.): Rs1,272,113.00
Shares Outstanding(Mil.): 2,399.31
Dividend: 3.50
Yield (%): 0.66

Financials

  SUN.BO Industry Sector
P/E (TTM): 28.37 30.95 32.75
EPS (TTM): 18.69 -- --
ROI: -- 14.84 14.38
ROE: -- 16.34 16.07

Indian shares drop on global cues, poised for weekly fall

May 4 Indian shares dropped on Friday tracking global equity markets, while IT and pharma stocks pulled down the indexes, ahead of elections in key southern state of Karnataka.

04 May 2018

MEDIA-Shanghvi's daughter to head consumer healthcare business at Sun Pharmaceutical Industries - Economic Times

- Note: Reuters has not verified this story and does not vouch for its accuracy

01 May 2018

BRIEF-Sun Pharmaceutical Industries' Unit Raises Stake In Ranbaxy Malaysia

* UNIT RAISED STAKE IN RANBAXY MALAYSIA VIA FURTHER PURCHASE OF 394,404 SHARES OF RANBAXY MALAYSIA

18 Apr 2018

TABLE-India Commercial Papers deals on F-TRAC-Apr 5

Apr 5 Following are the details of deals in Indian Commercial Papers reported on Clearcorp F-TRAC Platform. ISIN DESCRIPTION MATURITY WTG AVG WTG AVG NO OF TRADED LAST TRADED DATE PRICE YLD% TRADES VALUE* PRICE YIELD ============ ============ ======== ======= ======= ====== ===== =============== INE704I14AZ2 BARCLAYS INVEST 88D 13-Apr-18 99.8573 6.5200 3 115 99.8573

05 Apr 2018

TABLE-India Commercial Papers deals on F-TRAC-Apr 3

Apr 3 Following are the details of deals in Indian Commercial Papers reported on Clearcorp F-TRAC Platform. ISIN DESCRIPTION MATURITY WTG AVG WTG AVG NO OF TRADED LAST TRADED DATE PRICE YLD% TRADES VALUE* PRICE YIELD ============ ============ ======== ======= ======= ====== ===== =============== INE660N14AH4 S. D. CORPORATION 90D 4-Apr-18 99.9773 8.2874 1 7 99.9773

03 Apr 2018

BUZZ-India's Sun Pharma rises on U.S. FDA nod for skin disorder drug

** Shares of drugmaker Sun Pharmaceutical Industries Ltd rise as much as 3.27 pct to 521 rupees

22 Mar 2018

BRIEF-Sun Pharmaceutical Industries Gets U.S. FDA Nod Of ILUMYA (Tildrakizumab-Asmn)

* CO GETS U.S. FDA APPROVAL OF ILUMYA (TILDRAKIZUMAB-ASMN) FOR TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS Source text - http://bit.ly/2HRX8j1 Further company coverage:

21 Mar 2018

BUZZ-U.S. FDA clearance of Sun Pharma's Halol plant may take 4-6 mths - CS

** Sun Pharmaceutical Industries' Halol drug manufacturing plant may need four - six months to be cleared by the U.S. Food and Drug Administration (FDA), Credit Suisse analysts write in a note

06 Mar 2018

BRIEF-Sun Pharmaceutical Industries Says U.S. FDA Issued Form 483 With 3 Observations For Halol Facility

* SUN PHARMACEUTICAL INDUSTRIES -U.S. FDA CONDUCTED GMP INSPECTION OF HALOL FACILITY (GUJARAT, INDIA) FROM FEBRUARY 12-23, 2018

23 Feb 2018

Sun Pharma quarterly profit plunges on weak U.S. sales

India's largest drugmaker Sun Pharmaceutical Industries Ltd reported a 75 percent plunge in third-quarter net profit on Wednesday as pricing pressures in the United States, its biggest market, hit sales.

14 Feb 2018

Earnings vs. Estimates